Russell 2000 Rises 31%: Small-Cap Bets Under $30 Keep Running
The Russell 2000 has climbed roughly 31% over the past year, signaling a shift toward small-cap leadership. Two stock...
Monitoring budget adjustments effectively is vital for financial success. Learn simple tips to take control of your budgeting process.
19,560 articlesThe Russell 2000 has climbed roughly 31% over the past year, signaling a shift toward small-cap leadership. Two stock...
A major fund’s exit from Ocular Therapeutix raises questions about timing, liquidity, and sector signals. This articl...
As a looming recession tests crypto narratives, Bitcoin’s fixed supply and growing institutional interest face off ag...
Target delivered a solid beat-and-raise quarter, yet shares slid, illustrating a sell-the-news dynamic. With Walmart ...
Mizuho ups UnitedHealth's price target to $440, citing easing medical loss ratio pressures and a turning Medicare Adv...
A major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
Target Corp after latest earnings has investors weighing risk and reward. This guide breaks down what the numbers mea...
The race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
As Endava enters the back half of 2026, the Q3 earnings narrative centers on margin discipline, cloud-led growth, and...
A quiet, disciplined bet on the entire U.S. equity landscape. Pennington Partners increasing its stake in VTHR highli...
A hedge fund warns that a toxic cocktail of rising inflation and undercompensated bond yields could push the S&P 500 ...
QUBT surged alongside quantum peers on policy chatter, but the rally raises questions about fundamentals and governme...